The CDC’s ‘Undo It’ campaign aims to raise awareness among Americans about prediabetes, encouraging early screening and lifestyle modifications to prevent progression to type 2 diabetes and associated complications. The Centres for Disease Control and Prevention has begun airing a…
A six-week free workshop series commencing in Maui aims to provide practical, holistic support for individuals living with diabetes, blending clinical expertise with Native Hawaiian healing practices. A free six-week diabetes self-management workshop series will begin in Maui on September…
Recent insights highlight the importance of timing evening meals for better metabolic health, especially for those with demanding work schedules that extend late into the night. Aligning dinner with the body’s internal clock could support balanced blood sugar levels and…
Emerging research suggests that common diabetes medications like metformin and newer GLP-1 therapies may influence biological ageing pathways, sparking renewed interest and cautious optimism in extending healthspan for older adults. Metformin, a mainstay of type 2 diabetes care for decades,…
Emerging research underscores the importance of early detection and lifestyle interventions in managing insulin resistance, a precursor to type 2 diabetes, emphasising subtle symptoms and treatment options. WebMD says insulin resistance develops when the body’s muscle, liver and fat cells…
Pharmaceutical giant Eli Lilly has launched its innovative tirzepatide injection, Mounjaro, in Libya, offering a new dual-acting treatment to address the country’s escalating public health crisis of obesity and type 2 diabetes. Eli Lilly has launched Mounjaro, the tirzepatide injection,…
New research uncovers how chronic psychological stress induces astrocyte senescence in the amygdala, impairing brain metabolism and linking to disrupted blood sugar regulation, with potential implications for diabetes risk. A study published in Cell Metabolism suggests that chronic stress may…
A five-year clinical trial reveals that fenofibrate significantly increases levels of the metabolic hormone FGF21, prompting questions about its role in ageing and cardiovascular health among people with type 2 diabetes. A five-year randomised trial has found that fenofibrate, a…
A novel mathematical model named HOMA-C, based on fasting insulin and glucose, aims to better estimate pancreatic reserve capacity, potentially improving prediction of progression from prediabetes to type 2 diabetes. A new model described in PLOS Computational Biology proposes a…
A new American study indicates that prolonged use of the diabetes medication metformin may significantly lower the risk of developing dementia later in life, though researchers emphasise further research is necessary. A common medicine used to treat type 2 diabetes…
